Boehringer Ingelheim Foundations

Boehringer Ingelheim Foundation – excellence in science and regional commitment

Founded in 1977 by Hubertus Liebrecht, then managing partner of Boehringer Ingelheim. This non-profit organisation promotes the medical, biological, chemical and pharmaceutical sciences. Activities aim at funding basic research, for example with the Plus 3-Perspectives Programme for young leaders of independent research groups. From the outset, the foundation’s activities centred on the neighbouring University of Mainz, Germany. Since 1995, it has endowed the Boehringer Ingelheim Prize, awarded annually by the University of Mainz Faculty of Medicine for outstanding research in clinical and theoretical medicine. The foundation also contributed considerably to establish the Human Genetics Institute at the University of Mainz.

Since 2011, the foundation honours outstanding research with the celebrated Heinrich Wieland Prize. What is more, the foundation can support scientific events that act as a platform for an exchange of ideas between different generations of scientists.

In April 2013 the Boehringer Ingelheim Foundation announced the donation of EUR 50 million in funding over the next ten years to further promote the life sciences at Johannes Gutenberg University Mainz.

In 2009, the Boehringer Ingelheim Foundation decided, to make a special donation of EUR 100 million, an amount which remains almost unparalleled in Germany, towards the establishment of the Institute of Molecular Biology (IMB) and to fund its operations for ten years.

As one of the first institutions to help up-and-coming scientists in Germany to create independent research groups, the foundation also sponsors research projects in medicine, chemistry, pharmacy and biology throughout Germany.

Boehringer Ingelheim Fonds – fostering young researchers worldwide

In 1983, the Boehringer Ingelheim Fonds was established as a public foundation. An independent, non-profit institution, its purpose is the exclusive and direct promotion of basic research in biomedicine. The Boehringer Ingelheim Fonds supports the most talented young researchers worldwide whose PhD or MD projects are aimed at experimentally elucidating basic phenomena of human life.

Only the best applicants are accepted after an extremely rigorous application process.

Twice a year, the Boehringer Ingelheim Fonds invites scientists of worldwide repute to its International Titisee Conferences. Since 1962, experts from all nations have been meeting in the Black Forest (southern Germany) to discuss the latest results and developments in different areas of the molecular life sciences. Click here to read more about Boehringer Ingelheim Fonds.